Brian Hutzen

1.8k total citations
37 papers, 1.5k citations indexed

About

Brian Hutzen is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Brian Hutzen has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 22 papers in Genetics and 16 papers in Immunology. Recurrent topics in Brian Hutzen's work include Virus-based gene therapy research (22 papers), CAR-T cell therapy research (14 papers) and interferon and immune responses (7 papers). Brian Hutzen is often cited by papers focused on Virus-based gene therapy research (22 papers), CAR-T cell therapy research (14 papers) and interferon and immune responses (7 papers). Brian Hutzen collaborates with scholars based in United States, Netherlands and China. Brian Hutzen's co-authors include Jiayuh Lin, Sarah Ball, Stephanie Deangelis, Timothy P. Cripe, Pui‐Kai Li, Chenglong Li, Li Lin, Chun‐Yu Chen, Ling Cen and Elizabeth Foust and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Brian Hutzen

36 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Hutzen United States 22 859 683 371 283 198 37 1.5k
Nitin Chakravarti United States 22 682 0.8× 823 1.2× 146 0.4× 523 1.8× 93 0.5× 53 1.6k
Ramesh B. Batchu United States 25 446 0.5× 1.0k 1.5× 312 0.8× 415 1.5× 139 0.7× 55 1.7k
Ming‐Chei Maa Taiwan 22 378 0.4× 956 1.4× 86 0.2× 322 1.1× 63 0.3× 35 1.6k
Zhi Ming Shao China 15 776 0.9× 806 1.2× 224 0.6× 73 0.3× 306 1.5× 22 1.4k
Sandrine Dabernat France 22 389 0.5× 1.2k 1.8× 223 0.6× 74 0.3× 179 0.9× 55 1.7k
Thomas Jascur United States 18 390 0.5× 1.0k 1.5× 83 0.2× 285 1.0× 123 0.6× 25 1.4k
Qing Rao China 24 717 0.8× 1.0k 1.5× 170 0.5× 547 1.9× 65 0.3× 145 1.9k
Sophie Raynaud France 25 458 0.5× 1.2k 1.8× 150 0.4× 306 1.1× 316 1.6× 86 2.8k
Haitao Chen China 16 357 0.4× 445 0.7× 61 0.2× 178 0.6× 64 0.3× 56 969
Moira Sauane United States 24 1.1k 1.3× 998 1.5× 1.0k 2.8× 626 2.2× 106 0.5× 46 2.2k

Countries citing papers authored by Brian Hutzen

Since Specialization
Citations

This map shows the geographic impact of Brian Hutzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Hutzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Hutzen more than expected).

Fields of papers citing papers by Brian Hutzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Hutzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Hutzen. The network helps show where Brian Hutzen may publish in the future.

Co-authorship network of co-authors of Brian Hutzen

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Hutzen. A scholar is included among the top collaborators of Brian Hutzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Hutzen. Brian Hutzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hutzen, Brian, Chun‐Yu Chen, Pin-Yi Wang, et al.. (2024). Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors. Frontiers in Immunology. 15. 1384623–1384623. 1 indexed citations
2.
Hutzen, Brian, et al.. (2023). The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: Is there hope?. Molecular Therapy — Oncolytics. 30. 227–237. 7 indexed citations
3.
Cripe, Timothy P., Brian Hutzen, Mark A. Currier, et al.. (2022). Leveraging gene therapy to achieve long-term continuous or controllable expression of biotherapeutics. Science Advances. 8(28). eabm1890–eabm1890. 9 indexed citations
4.
Wedekind, Mary Frances, Katherine E. Miller, Chun‐Yu Chen, et al.. (2021). Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcoma. iScience. 24(7). 102759–102759. 4 indexed citations
5.
Chen, Chun‐Yu, Brian Hutzen, Mary Frances Wedekind, & Timothy P. Cripe. (2018). Oncolytic virus and PD-1/PD-L1 blockade combination therapy. PubMed. Volume 7. 65–77. 63 indexed citations
6.
Hutzen, Brian, Chun‐Yu Chen, Pin-Yi Wang, et al.. (2017). TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma. Molecular Therapy — Oncolytics. 7. 17–26. 37 indexed citations
7.
Studebaker, Adam, Brian Hutzen, Christopher R. Pierson, et al.. (2017). Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors. Molecular Therapy — Oncolytics. 6. 22–30. 36 indexed citations
8.
Cripe, Timothy P., Chun‐Yu Chen, Nicholas Denton, et al.. (2015). Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children. Molecular Therapy — Oncolytics. 2. 15015–15015. 20 indexed citations
9.
Studebaker, Adam, et al.. (2015). Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors. Neuro-Oncology. 17(12). 1568–1577. 23 indexed citations
10.
Chen, Chun‐Yao, Brian Hutzen, Michael Arnold, et al.. (2015). Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility. Gene Therapy. 23(2). 135–143. 26 indexed citations
11.
Studebaker, Adam, Corey Raffel, & Brian Hutzen. (2015). Advances in the design and development of oncolytic measles viruses. PubMed. 4. 109–109. 8 indexed citations
12.
Hutzen, Brian, Hemant K. Bid, Peter J. Houghton, et al.. (2014). Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin. BMC Cancer. 14(1). 206–206. 32 indexed citations
13.
Lin, Li, Brian Hutzen, Zhengang Peng, et al.. (2013). Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells. PLoS ONE. 8(12). e82821–e82821. 60 indexed citations
14.
Studebaker, Adam, Brian Hutzen, Christopher R. Pierson, et al.. (2012). Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma. Neuro-Oncology. 14(4). 459–470. 37 indexed citations
15.
Hutzen, Brian, Christopher R. Pierson, Stephen J. Russell, et al.. (2012). Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine. BMC Cancer. 12(1). 508–508. 33 indexed citations
16.
Lin, Li, Brian Hutzen, Mingxin Zuo, et al.. (2010). Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells. Cancer Research. 70(6). 2445–2454. 197 indexed citations
17.
Lin, Li, Brian Hutzen, Pui‐Kai Li, et al.. (2010). A Novel Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Activities and Exhibits Potent Growth-Suppressive Activity in Human Cancer Cells. Neoplasia. 12(1). 39–IN5. 166 indexed citations
18.
Fuh, Beng, Matthew Sobo, Brian Hutzen, et al.. (2009). LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model. British Journal of Cancer. 100(1). 106–112. 75 indexed citations
19.
20.
Ball, Sarah, et al.. (2007). Paracrine signaling from the breast cancer cells stimulates the cell proliferation and Stat3 phosphorylation in non-cancerous mammary epithelial cells and is blocked by dietary agent, curcumin.. Cancer Epidemiology and Prevention Biomarkers. 16. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nitin Chakravarti Breakdown of academic impact, for papers by Ramesh B. Batchu Breakdown of academic impact, for papers by Ming‐Chei Maa Breakdown of academic impact, for papers by Zhi Ming Shao Breakdown of academic impact, for papers by Sandrine Dabernat Breakdown of academic impact, for papers by Thomas Jascur Breakdown of academic impact, for papers by Qing Rao Breakdown of academic impact, for papers by Sophie Raynaud Breakdown of academic impact, for papers by Haitao Chen Breakdown of academic impact, for papers by Moira Sauane
Rankless by CCL
2026